The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine

Volume: 21, Issue: 2, Pages: e87 - e97
Published: Jun 1, 2022
Abstract
Previous pre-clinical research has indicated that the intestinal microbiota can potentiate anti-tumour efficacy of capecitabine and that capecitabine treatment impacts intestinal microbiota composition and diversity. Using a longitudinal design, this study explores the associations between the intestinal microbiota and treatment response in patients with metastatic colorectal cancer (mCRC) during capecitabine treatment.Patients with mCRC treated...
Paper Details
Title
The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine
Published Date
Jun 1, 2022
Volume
21
Issue
2
Pages
e87 - e97
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.